These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 10385266)

  • 1. Altered effects of acetylcholine on cyclic AMP and GMP induced changes in O2 consumption of hypertrophic dog cardiac myocytes.
    Gong GX; Straznicka M; Weiss HR; Tse J; Scholz PM
    J Auton Pharmacol; 1999 Feb; 19(1):19-28. PubMed ID: 10385266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclic GMP and cyclic AMP induced changes in control and hypertrophic cardiac myocyte function interact through cyclic GMP affected cyclic-AMP phosphodiesterases.
    Weiss HR; Gong GX; Straznicka M; Yan L; Tse J; Scholz PM
    Can J Physiol Pharmacol; 1999 Jun; 77(6):422-31. PubMed ID: 10537228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positive functional effects of milrinone and methylene blue are not additive in control and hypertrophic canine hearts.
    Leone RJ; Weiss HR; Scholz PM
    J Surg Res; 1998 Jun; 77(1):23-8. PubMed ID: 9698527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the cyclic GMP lowering agent LY83583 on the interaction of carbachol with forskolin in rabbit isolated cardiac preparations.
    MacLeod KM; Diamond J
    J Pharmacol Exp Ther; 1986 Jul; 238(1):313-8. PubMed ID: 3014120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of intracoronary nitroprusside on cyclic GMP and regional mechanics is altered in a canine model of left ventricular hypertrophy.
    Roitstein A; Kedem J; Cheinberg B; Weiss HR; Tse J; Scholz PM
    J Surg Res; 1994 Nov; 57(5):584-90. PubMed ID: 7967596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction in interaction between cGMP and cAMP in dog ventricular myocytes with hypertrophic failure.
    Zhang Q; Lazar M; Molino B; Rodriguez R; Davidov T; Su J; Tse J; Weiss HR; Scholz PM
    Am J Physiol Heart Circ Physiol; 2005 Sep; 289(3):H1251-7. PubMed ID: 16100251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T4-induced cardiac hypertrophy disrupts cyclic GMP mediated responses to brain natriuretic peptide in rabbit myocardium.
    Katz E; Zhang Q; Weiss HR; Scholz PM
    Peptides; 2006 Sep; 27(9):2276-83. PubMed ID: 16762459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of cAMP metabolism in mouse parotid gland by cGMP and calcium.
    Watson EL; Singh JC; McPhee C; Beavo J; Jacobson KL
    Mol Pharmacol; 1990 Oct; 38(4):547-53. PubMed ID: 1700270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Action of acetylcholine on regional myocardial work and metabolism in vivo: association with cyclic GMP.
    Guo X; Kedem J; Scholz PM; Weiss HR
    Can J Physiol Pharmacol; 1996 Jan; 74(1):73-9. PubMed ID: 8963954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of phosphodiesterase in regulation of calcium current in isolated cardiac myocytes.
    Simmons MA; Hartzell HC
    Mol Pharmacol; 1988 Jun; 33(6):664-71. PubMed ID: 2454387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exogenous nitric oxide reduces oxygen consumption of isolated ventricular myocytes less than other forms of guanylate cyclase stimulation.
    Gong GX; Weiss HR; Tse J; Scholz PM
    Eur J Pharmacol; 1998 Mar; 344(2-3):299-305. PubMed ID: 9600666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heart failure reduces both the effects and interaction between cyclic GMP and cyclic AMP.
    Moalem J; Weiss HR; Davidov T; Rodriguez R; Molino B; Lazar MJ; Scholz PM
    J Surg Res; 2006 Aug; 134(2):300-6. PubMed ID: 16545395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Importance of ryanodine receptors in effects of cyclic GMP is reduced in thyroxine-induced cardiac hypertrophy.
    Zhang Q; Goel N; Rodriguez R; Scholz PM; Weiss HR
    Eur J Pharmacol; 2006 May; 537(1-3):45-51. PubMed ID: 16626695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pacing-induced cardiac failure of hypertrophic hearts: effects of cyclic GMP reduction.
    Huang MW; Weiss HR; Tse J; Leone RJ; Scholz PM
    J Surg Res; 1999 Sep; 86(1):89-96. PubMed ID: 10452873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positive inotropy due to lowering cyclic GMP is also mediated by increases in cyclic AMP in control and hypertrophic hearts.
    Naim KL; Rabindranauth P; Weiss HR; Tse J; Leone RJ; Scholz PM
    Can J Physiol Pharmacol; 1998 Jun; 76(6):605-12. PubMed ID: 9923398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased guanylate cyclase activity is associated with an increase in cyclic guanosine 3',5'-monophosphate in left ventricular hypertrophy.
    Sadoff JD; Scholz PM; Tse J; Weiss HR
    J Clin Invest; 1996 Aug; 98(3):838-45. PubMed ID: 8698876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guanylyl cyclase inhibition reduces contractility and decreases cGMP and cAMP in isolated rat hearts.
    Klabunde RE; Tse J; Weiss HR
    Cardiovasc Res; 1998 Mar; 37(3):676-83. PubMed ID: 9659451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Negative functional effects of natriuretic peptides are attenuated in hypertrophic cardiac myocytes by reduced particulate guanylyl cyclase activity.
    Meyer M; Zhang Q; Khurana K; Scholz PM; Weiss HR
    J Cardiovasc Pharmacol; 2007 Feb; 49(2):100-5. PubMed ID: 17312451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction between the opposing functional effects of cyclic AMP and cyclic GMP in hypertrophic cardiac myocytes.
    Patel KN; Yan L; Gandhi A; Scholz PM; Weiss HR
    Basic Res Cardiol; 2001 Feb; 96(1):34-41. PubMed ID: 11215530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of cyclic GMP and its protein kinase on the contraction of ventricular myocytes from hearts after cardiopulmonary arrest.
    Su J; Scholz PM; Tse J; Weiss HR
    Can J Physiol Pharmacol; 2004 Nov; 82(11):986-92. PubMed ID: 15644938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.